AAFP Still Recommends CRC Screening From Age 50 to 75

Share this content:
AAFP Still Recommends CRC Screening From Age 50 to 75
AAFP Still Recommends CRC Screening From Age 50 to 75

WEDNESDAY, June 20, 2018 (HealthDay News) -- In accordance with the U.S. Preventive Services Task Force (USPSTF), the American Academy of Family Physicians (AAFP) does not intend to change its recommendations for colorectal cancer screening based on the recent change in the American Cancer Society (ACS) guideline.

The ACS recently released an updated guideline recommending colorectal cancer screening starting at age 45 years for average-risk patients, in contrast to the USPSTF guideline, released June 2016, which recommends screening from age 50 through 75 years. The ACS acknowledged that the recommendation on screening those aged 45 to 49 years is graded as a qualified recommendation, as it relies on use of modeling without clinical trial-based evidence.

The AAFP agrees with the USPSTF recommendation for screening patients at ages 50 to 75 years, and graded its recommendation B. In addition, the AAFP offered a preferential recommendation for specific screening tests: fecal immunochemical tests, flexible sigmoidoscopy, and colonoscopy.

The ACS "assumed that colon cancer in younger adults is similar to cancer that occurs in older adults, and that screening would have the same benefits and no additional harms," Jennifer Frost, M.D., medical director for the AAFP's Health of the Public and Science Division, said in a statement. "Individual family physicians, in conversation with their patients, will decide whether earlier screening is appropriate. The AAFP will review empirical evidence once it is available."

AAFP Recommendation
ACS Policy Update

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Increase Seen in Salmonella Illnesses From Ground Beef

CDC: Increase Seen in <i>Salmonella</i> Illnesses From Ground ...

246 people now sickened; 59 people have been hospitalized; no deaths reported to date

Epinephrine Personal Autoinjectors Cost-Effective at 24

Epinephrine Personal Autoinjectors Cost-Effective at &#36;24

Based on 10-fold fatality risk difference, value-based price for personal epinephrine $24

Burden of Liver Cancer Rising in Medicare Patients

Burden of Liver Cancer Rising in Medicare Patients

Coexistence of other liver conditions tied to even higher risk for death, health care costs

is free, fast, and customized just for you!




Already a member?

Sign In Now »